根據最新的財務報表(Form-10K),Organigram Global Inc. 的總資產為 $0,淨損失為 $0
OGI 的關鍵財務比率是什麼?
Organigram Global Inc. 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Organigram Global Inc. 的收入按細分市場或地理位置如何劃分?
Organigram Global Inc. 最大收入來源為 Adult-use Recreational Wholesale,在最近的收益報告中收入為 230,387,000。就地區而言,Canada 是 Organigram Global Inc. 的主要市場,收入為 237,429,000。
Organigram Global Inc. 是否盈利?
無,根據最新的財務報表,Organigram Global Inc. 的淨損失為 $0
Organigram Global Inc. 有負債嗎?
無,Organigram Global Inc. 的負債為 0
Organigram Global Inc. 的流通股有多少?
Organigram Global Inc. 的總流通股為 0
關鍵數據
前收市價
$1.04
開盤價
$1.04
當日範圍
$1.04 - $1.09
52週區間
$1.04 - $2.24
交易量
623.4K
平均成交量
696.4K
股息收益率
--
每股盈餘 (TTM)
0.11
市值
$151.8M
什麼是 Organigram Global Inc.?
Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,137 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.